TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · major macro event coming up
NSPR

InspireMD Inc

Healthcare · Medical Devices

0.6579$ +22.1% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns InspireMD Inc (NSPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.8% of the shares are freely tradable; institutional investors hold 48.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 48.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 19.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 61.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 47Mio.

Largest Shareholders

Institutions

Institutions NSPR
Name Stake (%) Shares Change (%) Date
Nantahala Capital Management, LLC 14.39 6,752,968 +100.0 06/30/2026
Rosalind Advisors, Inc. 8.32 3,905,743 +0.0 06/30/2026
Aberdeen Group PLC 7.88 3,698,364 +16.5 06/30/2026
Orbimed Advisors LLC 6.68 3,133,405 +0.0 06/30/2026
Parkman Healthcare Partners LLC 5.15 2,416,518 +0.0 06/30/2026
Marshall Wace Asset Management Ltd 3.97 1,860,405 +0.0 06/30/2026
Soleus Capital Management, L.P. 2.23 1,045,708 +0.0 06/30/2026

Funds

Funds NSPR
Name Stake (%) Shares Change (%) Date
abrdn Healthcare Investors 3.72 1,743,519 +0.0 09/30/2026
abrdn Healthcare Opportunities 2.68 1,259,385 +0.0 09/30/2026
abrdn World Healthcare 1.48 695,460 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?